SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-445216
Filing Date
2016-02-01
Accepted
2016-02-01 08:02:31
Documents
7
Period of Report
2016-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d121489d8k.htm 8-K 37294
2 EX-2.1 d121489dex21.htm EX-2.1 428194
3 EX-10.1 d121489dex101.htm EX-10.1 41529
4 EX-10.2 d121489dex102.htm EX-10.2 62225
5 EX-10.3 d121489dex103.htm EX-10.3 43401
6 EX-99.1 d121489dex991.htm EX-99.1 17568
7 GRAPHIC g121489g44u09.jpg GRAPHIC 5945
  Complete submission text file 0001193125-16-445216.txt   639945
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 161375419
SIC: 2836 Biological Products, (No Diagnostic Substances)